Canada awards new patent to bioaffinity technologies for cypath® lung, company's noninvasive lung cancer diagnostic

San antonio--(business wire)-- #biaf--canada grants bioaffinity technologies new patent that protects its proprietary technology that powers its flagship product, cypath® lung.

BIAF Ratings Summary

BIAF Quant Ranking